Italia markets close in 5 hours 42 minutes

JNJ Sep 2024 170.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,24000,0000 (0,00%)
In data: 03:59PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,2400
Aperto0,3100
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio170,00
Scadenza2024-09-20
Min-Max giorno0,2400 - 0,3100
Contratto - Min-MaxN/D
Volume4
Open InterestN/D
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA